Company / Cash per Share
FENNEC PHARMACEUTICALS INC. Cash per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.34
FY2025
5-year range
$0.50 / $1.34
FY2021-FY2025
Trend
+35.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2016 to $1.53 in FY2018.
Based on SEC 10-K filings.
1.34 in FY2025 with a 10-year CAGR of +19.9%.
Improved from $0.50 to $1.34 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +19.9%
Key checks
Key Insights
- In FY2025, cash per share increased 35.6% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.34 | +35.6% |
| FY2024 | $0.99 | +95.8% |
| FY2023 | $0.50 | -38.0% |
| FY2021 | $0.81 | -29.1% |
| FY2019 | $1.15 | -25.4% |
| FY2018 | $1.53 | +433.4% |
| FY2017 | $0.29 | +234.2% |
| FY2016 | $0.09 | -60.5% |
| FY2015 | $0.22 | +27.3% |
| FY2014 | $0.17 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026